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ABSTRACT 
The in vitro antibacterial and antibiofilm activity of chlorogenic acid against clinical isolates 
of Stenotrophomonas maltophilia was investigated through disk diffusion, minimum 
inhibitory concentration (MIC), minimum bactericidal concentration (MBC), time-kill and 
biofilm assays. A total of 9 clinical S. maltophilia isolates including one isolate resistant to 
trimethoprim / sulfamethoxazole (TMP/SMX) were tested. The inhibition zone sizes for the 
isolates ranged from 17 to 29 mm, while the MIC and MBC values ranged from 8 to 16 g 
mL-1 and 16 to 32 g mL-1. Chlorogenic acid appeared to be strongly bactericidal at 4x MIC, 
with a 2-log reduction in viable bacteria at 10 h. In vitro antibiofilm testing showed a 4-fold 
reduction in biofilm viability at 4x MIC compared to 1x MIC values (0.085 < 0.397 A 490 
nm) of chlorogenic acid. The data from this study support the notion that the chlorogenic acid 
has promising in vitro antibacterial and antibiofilm activities against S. maltophilia. 
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